Activity value 72china Supplier,Last transaction date:
2026-05-14
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for shenzhen zhijun medical pharmaceutical trading from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 3 transactions, with a transaction quantity of 1361.21 and a transaction weight of 1797.9.
YearTransactionsQuantityWeight
2025142207.695019.91
202631361.211797.9
Bill of lading data
<
1/15
>
Trade date
2025/11/10
B/L No.
smg25100717
Suppliers
shenzhen zhijun medical pharmaceutical trading
Buyers
dynasty pharmaceuticals
Product description
42 CTNS (9,900 VIALS) OF (SEFPIME) CEFEPIME HYDROCHLORIDE FOR INJ. 2.0G BATCH 250935 DATE OF MFG. 2025-09-19 DATE OF EXP. 2027-09
Expand
Trade date
2025/11/10
B/L No.
smg25100717
Suppliers
shenzhen zhijun medical pharmaceutical trading
Buyers
dynasty pharmaceuticals
Product description
19 CTNS (9,670 VIALS) OF (TRIXOPHIN) CEFTRIAXONE SODIUM FOR INJ. 1.0G BATCH 250938 DATE OF MFG. 2025-09-18 DATE OF EXP. 2028-03
Expand
Trade date
2025/11/10
B/L No.
smg25100717
Suppliers
shenzhen zhijun medical pharmaceutical trading
Buyers
dynasty pharmaceuticals
Product description
135 CTNS SHIPPERS LOAD, COUNT AND SEAL STC 35 CTNS (18,160 VIALS) OF (AERUGINOX) CEFUROXIME SODIUM FOR INJ. 0.75G BATCH 250920 DATE OF MFG. 2025-09-13 DATE OF EXP. 2027-09
Expand
Trade date
2025/11/10
B/L No.
smg25100717
Suppliers
shenzhen zhijun medical pharmaceutical trading
Buyers
dynasty pharmaceuticals
Product description
118 CTNS SLCAS SAID TO CONTAIN 39 CTNS (22,650 VIALS) OF (AERUM) CEFTAZIDIME FOR INJ. 1.0G BATCH 250401, 250402 DATE OF MFG. 2025-04-03 DATE OF EXP. 2027-04
Expand
Trade date
2025/06/09
B/L No.
smg25050717
Suppliers
shenzhen zhijun medical pharmaceutical trading
Buyers
dynasty pharmaceuticals
Product description
37 CTNS SLCAS 18 CTNS (10,330 VIALS) OF CEFTRIAXONE SODIUM FOR INJ. 1.0G BATCH 250106 DATE OF MFG. 2025-01-05 DATE OF EXP. 2027-01
Expand
Trade date
2025/03/19
B/L No.
smg25020713
Suppliers
shenzhen zhijun medical pharmaceutical trading
Buyers
dynasty pharmaceuticals
POLs
——
PODs
manila international container terminal
Product description
19 CTNS (9,540 VIALS) OF (TRIXOPHIN) CEFTRIAXONE SODIUM FOR INJ. 1.0G BATCH 250107 DATE OF MFG. 2025-01-05 DATE OF EXP. 2027-07
Expand
Trade date
2025/02/17
B/L No.
smg25010416
Suppliers
shenzhen zhijun medical pharmaceutical trading
Buyers
dynasty pharmaceuticals
shenzhen zhijun medical pharmaceutical trading is china Supplier,
and primarily engages in the import and export business of products such as vial,bat,ceftriaxone sodium.
According to the 52wmb.com global trade database, as of 2026-05-14, the company has completed 21 international trades,
with its main trading regions covering philippines,sri lanka,pakistan etc.
The core products include HS30042099000,HS30042039000 etc,
often transported via shenzhen etc,
and its main trading partners are dynasty pharmaceuticals,population services lanka,zumars pharma fty pvt ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on shenzhen zhijun medical pharmaceutical trading is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.